Sanofi

(NASDAQ:SNY)

Latest On Sanofi (SNY):

Date/Time Type Description Signal Details
2023-05-31 12:34 ESTNewsSanofi mulls pivotal trials for multiple sclerosis candidate after Phase 2 winN/A
2023-05-25 05:56 ESTDividendA dividend of $1.9 has been announced on Feb 15, 2023. It will be paid Jun 23, 2023 with an ex-dividend date of May 25, 2023.Neutral
2023-05-19 17:21 ESTNewsSobi's hemophilia A therapy gets review in EUN/A
2023-05-18 13:01 ESTNewsSupreme Court rules against Amgen in Repatha patent dispute with Sanofi/ RegeneronN/A
2023-05-02 16:16 ESTNewsEli Lilly, Sanofi to cap insulin prices at $35 per month for uninsured New YorkersN/A
2023-05-01 15:39 ESTNewsSanofi stock rises on licensing deal with Maze for potential Pompe disease drugN/A
2023-05-01 15:39 ESTNewsEledon stock rises ~10% after up to $185M financingN/A
2023-04-29 01:35 ESTNewsSanofi cut to to sell at Deutsche Bank on Q1 results, outlookN/A
2023-04-28 00:47 ESTNewsSanofi SA (SNY) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 12:04 ESTNewsSanofi reports mixed Q1 earnings; reaffirms FY23 outlookN/A
2023-04-27 12:04 ESTNewsSanofi Q1 profit climbs on Dupixent as drug on track for €10B this yearN/A
2023-04-27 12:03 ESTNewsSanofi completes Provention Bio acquisitionN/A
2023-04-26 11:33 ESTNewsProvention Bio gains after HSR waiting period for Sanofi deal expiredN/A
2023-04-18 03:55 ESTNewsSanofi: The Growth Engine Is Slowly Picking Up SteamN/A
2023-04-17 14:25 ESTNewsSupreme Court turns down Sanofi bid to revive EpiPen lawsuit against ViatrisN/A
2023-04-14 18:49 ESTNewsGhana 1st in world to approve new malaria vaccine by OxfordN/A
2023-04-11 05:39 ESTNewsSanofi withdraws and refiles pre-merger notification, report form to acquire Provention BioN/A
2023-04-05 14:49 ESTNewsSanofi, BARDA break ground on new flu vaccine facility at Pennsylvania siteN/A
2023-04-04 05:38 ESTNewsLancet highlights potential of Sanofi's troubled hemophilia drug fitusiranN/A
2023-03-31 12:40 ESTNewsSanofi plans to spin-off consumer business in India - reportN/A
2023-03-29 20:30 ESTNewsRegeneron Libtayo gets expanded approval in EU for lung cancer subtypeN/A
2023-03-27 22:52 ESTNewsSupreme Court hears arguments in Amgen Repatha patent case against SanofiN/A
2023-03-23 10:15 ESTNewsSanofi stock rises as Dupixent shows benefit in lung disease smokers, meets phase 3 goalsN/A
2023-03-21 12:16 ESTNewsSanofi and Regeneron's Dupixent gets approval in EU to treat eczema in kids over 6 monthsN/A
2023-03-17 16:30 ESTNewsAcer stock slumps ~45% as ACER-801 paused after hot flashes trial disappoints; cash woesN/A
2023-03-17 01:31 ESTNewsSanofi cuts list price on Lantus insulin by 78% in the U.S.N/A
2023-03-13 05:53 ESTNewsProvention Bio stock rockets 260% on ~$2.9B acquisition by SanofiN/A
2023-03-07 11:58 ESTNewsFDA accepts for review Regeneron/Sanofi's Dupixent application for inflammatory skin conditionN/A
2023-03-02 08:59 ESTNewsSanofi's hemophilia A therapy Altuviiio meets main goal in trial, setting stage for EU filingN/A
2023-02-24 10:36 ESTNewsSanofi wins FDA nod for once-weekly bleeding disorder therapyN/A
2023-02-21 18:10 ESTNewsAstraZeneca, Sanofi BLA for nirsevimab for respiratory syncytial virus accepted by FDAN/A
2023-02-13 13:10 ESTNewsSanofi head of R&D to depart; eyes launch of 2 new drugs for hemophilia, RSV in 2023N/A
2023-02-04 03:26 ESTNewsSanofi SA (SNY) Q4 2022 Earnings Call TranscriptN/A
2023-02-04 03:25 ESTNewsSanofi: Increasing Our Long PositionN/A
2023-02-03 14:38 ESTNewsSanofi Non-GAAP EPS of €1.71 in-line, revenue of €10.72B misses by €260M; initiates FY23 guidanceN/A
2023-02-03 14:38 ESTNewsSanofi stock dips as Q4 revenue grows but vaccine sales fall; Dupixent drives moderate profit outlookN/A
2023-02-03 14:37 ESTNewsSanofi proposes annual dividend of €3.56N/A
2023-02-03 14:37 ESTNewsSanofi puts brakes on phase 3 trials of myasthenia gravis candidate tolebrutinibN/A
2023-02-02 11:19 ESTNewsSanofi Q4 2022 Earnings PreviewN/A
2023-01-31 21:57 ESTNewsHaleon said to evaluate potential deals to increase its size - reportN/A
2023-01-31 08:54 ESTNewsSanofi to lay off employees at 2 vaccine facilities in IndiaN/A
2023-01-30 07:36 ESTNewsSanofi, Regeneron Dupixent gets approval in EU for expanded use in eosinophilic esophagitisN/A
2023-01-27 15:07 ESTNewsSanofi, Regeneron Dupixent gets EMA panel nod to treat eczema in kids under 5N/A
2023-01-26 00:03 ESTNewsDenali to get $25M milestone as Sanofi begins dosing in multiple sclerosis studyN/A
2023-01-25 09:53 ESTNewsInnate, Sanofi licensing deal gets US antitrust clearanceN/A
2023-01-23 21:04 ESTNewsSanofi, CytoReason expanding collaboration to AI for inflammatory bowel disease targetsN/A
2023-01-13 15:49 ESTNewsJohnson & Johnson is scaling back COVID-19 vaccine production – WSJN/A
2023-01-11 04:11 ESTNewsSanofi SA (SNY) CEO Paul Hudson Presents at 41st Annual J.P. Morgan Healthcare Conference (Transcript)N/A
2022-12-22 05:58 ESTNewsGSK, Sanofi COVID booster vaccine gets approval in UKN/A
2022-12-21 13:25 ESTNewsGlaxoSmithKline, Sanofi led European pharmas in stock performance in OctoberN/A

About Sanofi (SNY):

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. It also has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

SNY Quotes by TradingView

See Advanced Chart

General

  • Name Sanofi
  • Symbol SNY
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-General
  • Full Time Employees 99,412
  • Last Split Factor5:1
  • Last Split Date2013-09-30
  • Fiscal Year EndDecember
  • IPO Date2002-07-01
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.sanofi.com
View More

Valuation

  • Trailing PE 25.31
  • Forward PE 13.4
  • Price/Sales (Trailing 12 Mt.) 2.78
  • Price/Book (Most Recent Quarter) 1.63
  • Enterprise Value Revenue 3.54
  • Enterprise Value EBITDA 8.33
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $3.71
  • Next Year EPS Estimate $4.31
  • Profit Margin 33%
  • Return on Assets 4%
  • Return on Equity 20%
  • Earnings Per Share $1.94
  • Revenue Per Share $0
  • Gross Profit 25.27 billion
  • Quarterly Earnings Growth -2.8%
View More

Highlights

  • Market Capitalization 121.59 billion
  • PE Ratio 19.23
  • PEG Ratio 3.67
  • Analyst Target Price $64.67
  • Book Value Per Share $26.25
View More

Share Statistics

  • Shares Outstanding 2.5 billion
  • Shares Float 2.22 billion
  • % Held by Insiders <1%
  • % Held by Institutions 7.04%
  • Shares Short 5.41 million
  • Shares Short Prior Month 6.43 million
  • Short Ratio 1.51
View More

Technicals

  • Beta 0.35
  • 52 Week High $55
  • 52 Week Low $36.32
  • 50 Day Moving Average 47.28
  • 200 Day Moving Average 49.01
View More

Dividends

  • Forward Annual Dividend Rate $1.7
  • Forward Annual Dividend Yield 3.46%
  • Payout Ratio 51%
  • Dividend Date 2020-05-26
  • ExDividend Date 2020-04-30
  • Dividend Per Share $3.53
  • Dividend Yield 4.19%
View More

Sanofi (SNY) Dividend Calendar:

Sanofi pays an annual dividend of $1.7 per share, with a dividend yield of 4.19%.
SNY's last dividend payment was made to shareholders on May 26, 2020.
Sanofi pays out 51% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Sanofi (SNY) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-05$9.74 billion$0.73$1.05-30.26%
2020-09-302020-10-29$N/A$1.08$1.034.82%
2020-06-302020-07-29$8.44 billion$0.75$0.6417.58%
2020-03-312020-04-24$N/A$0.88$0.827.62%
2019-12-312020-02-06$11.23 billion$0.74$0.696.86%
2019-09-302019-10-31$10.81 billion$1.07$1.043%
2019-06-302019-07-29$10.2 billion$0.73$0.721.46%
2019-03-312019-04-26$9.77 billion$0.79$0.772.38%
2018-12-312019-02-07$10.7 billion$0.63$0.67-6.53%
2018-09-302018-10-31$11.28 billion$1.04$1.003.9%
2018-06-302018-07-31$9.87 billion$0.73$0.721.25%
2017-12-312018-02-07$11.37 billion$0.65$1.04-37.19%
2017-09-302017-11-02$11.82 billion$1.00$0.963.34%
2017-06-302017-07-31$10.84 billion$0.80$0.764.51%
2017-03-312017-04-28$9.52 billion$0.77$0.7010.33%
2016-12-312017-02-08$7.93 billion$0.67$0.670.19%
2016-09-302016-10-28$10.78 billion$0.98$0.8021.95%
2016-06-302016-07-29$8.88 billion$0.73$0.721.79%
2016-03-312016-04-29$9.03 billion$0.77$0.77-0.84%
2015-12-312016-02-09$8.79 billion$0.75$0.714.85%
2015-09-302015-10-29$10.13 billion$0.90$0.882.27%
2015-06-302015-07-30$10.11 billion$0.55
2013-12-312014-02-06$12.38 billion$0.93$1.28-27.34%
2012-12-312013-02-07$12.32 billion$0.77$1.55-50.32%
2012-09-302012-10-25$12.22 billion$1.05$1.92-45.31%
2011-12-312012-02-08$10.33 billion$1.05$1.59-33.96%
2011-09-302011-11-03$10.51 billion$1.26$1.214.13%
2009-12-312010-02-10$10.39 billion$1.01$2.06-50.97%
2008-12-312009-02-11$10.03 billion$0.83$1.79-53.63%
2008-03-312008-04-30$11.41 billion$1.06$5.42-80.44%
2007-12-312008-02-12$11.39 billion$0.79$0.80-1.25%
2007-09-302007-10-31$11.44 billion$0.94$0.8510.59%
2007-06-302007-08-01$9.88 billion$0.84$0.89-5.62%
2007-03-312007-05-03$9.94 billion$1.03$0.8718.39%
2006-12-312007-02-13$11.13 billion$0.66$0.5911.86%
2006-09-302006-10-31$8.93 billion$0.80$0.7112.68%
2006-06-302006-08-02$9.98 billion$0.84$0.787.69%
2006-03-312006-05-05$8.89 billion$0.97$0.8810.23%
2005-12-312006-02-24$8.24 billion$0.64$0.631.59%
2005-09-302005-11-08$9.01 billion$0.88$0.7320.55%
2005-06-302005-08-31$7.88 billion$0.73$0.687.35%
2005-03-312005-05-13$8.64 billion$0.70$0.657.69%

Sanofi (SNY) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Sanofi (SNY) Chart:

Sanofi (SNY) News:

Below you will find a list of latest news for Sanofi (SNY) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Sanofi (SNY) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-17250CALL0 0122.9TRUE00
2024-05-1727.50CALL0 0105.5TRUE00
2024-05-17300CALL0 0107.63TRUE00
2024-05-1732.50CALL0 079.63TRUE00
2024-05-17350CALL0 064.91TRUE00
2024-05-1737.59.97CALL0 156.41TRUE00
2024-05-17400CALL0 041.66TRUE00
2024-05-1742.50CALL0 054.95TRUE00
2024-05-17451.65CALL2 15527.49TRUE1.650
2024-05-1747.50.45CALL12 138225.16FALSE-0.35-0.44
2024-05-17500.2CALL125 22729.45FALSE0.050.33
2024-05-1752.50.05CALL0 680FALSE00
2024-05-17550.25CALL0 60FALSE00
2024-05-1757.50.24CALL0 470FALSE00
2024-05-17600CALL0 00FALSE00
2024-05-17650CALL0 00FALSE00
2024-05-17250PUT0 00FALSE00
2024-05-1727.50PUT0 00FALSE00
2024-05-17300PUT0 00FALSE00
2024-05-1732.50PUT0 00FALSE00
2024-05-17350PUT0 00FALSE00
2024-05-1737.50.15PUT0 841.15FALSE00
2024-05-17400.31PUT0 4838.09FALSE00
2024-05-1742.50.8PUT28 1838.03FALSE0.150.23
2024-05-17452PUT155 120142.09FALSE0.350.21
2024-05-1747.52.85PUT0 17939.46TRUE00
2024-05-17504.6PUT0 563.33TRUE00
2024-05-1752.50PUT0 074.46TRUE00
2024-05-17550PUT0 083.81TRUE00
2024-05-1757.50PUT0 093.18TRUE00
2024-05-17600PUT0 0104.46TRUE00
2024-05-17650PUT0 0123.78TRUE00
2024-06-21250CALL0 0129.14TRUE00
2024-06-2127.50CALL0 072.08TRUE00
2024-06-21300CALL0 089.22TRUE00
2024-06-2132.50CALL0 081.43TRUE00
2024-06-21350CALL0 058.82TRUE00
2024-06-2137.510CALL0 043TRUE00
2024-06-21400CALL0 033.37TRUE00
2024-06-2142.54.39CALL0 642.87TRUE00
2024-06-21452.95CALL0 18721.14TRUE00
2024-06-2147.50.6CALL157 160920.22FALSE0.60
2024-06-21500.25CALL1 43421.72FALSE-0.14-0.36
2024-06-2152.50.14CALL0 2510FALSE00
2024-06-21550.05CALL0 14320FALSE00
2024-06-2157.50.07CALL0 2840FALSE00
2024-06-21600.35CALL0 220FALSE00
2024-06-2162.50.25CALL0 40FALSE00
2024-06-21650CALL0 00FALSE00
2024-06-21700.2CALL0 10FALSE00
2024-06-21750.1CALL0 20FALSE00
2024-06-21800CALL0 00FALSE00
2024-06-21250PUT0 00FALSE00
2024-06-2127.50.05PUT0 800FALSE00
2024-06-21300.05PUT0 270FALSE00
2024-06-2132.50.35PUT0 630FALSE00
2024-06-21350.16PUT0 7441.6FALSE00
2024-06-2137.50.15PUT0 18231.37FALSE00
2024-06-21400.47PUT1 41729.44FALSE0.470
2024-06-2142.51PUT21 38327.52FALSE10
2024-06-21452.25PUT68 65830FALSE0.250.13
2024-06-2147.53.1PUT0 109928.57TRUE00
2024-06-21503.1PUT0 69944.69TRUE00
2024-06-2152.55.1PUT0 5249.85TRUE00
2024-06-21555PUT0 251.54TRUE00
2024-06-2157.510.2PUT0 3061.64TRUE00
2024-06-216012.5PUT0 2567.38TRUE00
2024-06-2162.516.5PUT0 575.7TRUE00
2024-06-21650PUT0 064.97TRUE00
2024-06-217024PUT0 5291.49TRUE00
2024-06-21750PUT0 0101.3TRUE00
2024-06-21800PUT0 0110.25TRUE00
2024-09-20250CALL0 087.07TRUE00
2024-09-2027.50CALL0 059.31TRUE00
2024-09-203022CALL0 152.82TRUE00
2024-09-2032.50CALL0 046.04TRUE00
2024-09-20350CALL0 042.32TRUE00
2024-09-2037.512.15CALL0 132.38TRUE00
2024-09-20406.68CALL0 5240.1TRUE00
2024-09-2042.57.1CALL0 029.1TRUE00
2024-09-20453.29CALL0 622.67TRUE00
2024-09-2047.51.7CALL0 4922.54FALSE00
2024-09-20500.65CALL2 46020.8FALSE-0.35-0.35
2024-09-2052.50.6CALL0 13822.05FALSE00
2024-09-20550.25CALL0 72121.37FALSE00
2024-09-2057.50.19CALL0 120FALSE00
2024-09-20600.25CALL0 360FALSE00
2024-09-20650CALL0 00FALSE00
2024-09-20700CALL0 00FALSE00
2024-09-20750CALL0 00FALSE00
2024-09-20250PUT0 00FALSE00
2024-09-2027.50PUT0 00FALSE00
2024-09-20300PUT0 00FALSE00
2024-09-2032.50PUT0 00FALSE00
2024-09-20350.3PUT0 628.02FALSE00
2024-09-2037.50.25PUT0 324.72FALSE00
2024-09-20400.95PUT0 6022.57FALSE00
2024-09-2042.51.7PUT20 49322.46FALSE0.150.1
2024-09-20452.8PUT86 3921.43FALSE2.80
2024-09-2047.53.23PUT0 23725.89TRUE00
2024-09-20504.9PUT0 1215.23TRUE00
2024-09-2052.58.8PUT2 027.31TRUE8.80
2024-09-20550PUT0 026.39TRUE00
2024-09-2057.59.1PUT0 1035.26TRUE00
2024-09-206011.9PUT0 531.63TRUE00
2024-09-20650PUT0 049.12TRUE00
2024-09-20700PUT0 054.44TRUE00
2024-09-20750PUT0 059.74TRUE00
2024-12-2027.50CALL0 054.41TRUE00
2024-12-20300CALL0 049.23TRUE00
2024-12-2032.50CALL0 041.77TRUE00
2024-12-20350CALL0 056.96TRUE00
2024-12-2037.50CALL0 040.44TRUE00
2024-12-20400CALL0 024.27TRUE00
2024-12-2042.50CALL0 029.92TRUE00
2024-12-20450CALL0 025.16TRUE00
2024-12-2047.50CALL0 023.52FALSE00
2024-12-20500CALL0 021.44FALSE00
2024-12-2052.50CALL0 024.42FALSE00
2024-12-20550CALL0 024.72FALSE00
2024-12-20600CALL0 026.09FALSE00
2024-12-2027.50PUT0 00FALSE00
2024-12-20300PUT0 063FALSE00
2024-12-2032.50PUT0 027.62FALSE00
2024-12-20350PUT0 030.44FALSE00
2024-12-2037.50PUT0 023.7FALSE00
2024-12-20400PUT0 021.46FALSE00
2024-12-2042.52.2PUT1 019.84FALSE2.20
2024-12-20450PUT0 019.44FALSE00
2024-12-2047.50PUT0 018.01TRUE00
2024-12-20500PUT0 013.55TRUE00
2024-12-2052.50PUT0 031.2TRUE00
2024-12-20550PUT0 020.28TRUE00
2024-12-20600PUT0 022.81TRUE00
2025-01-172023.8CALL0 474.47TRUE00
2025-01-17250CALL0 064.1TRUE00
2025-01-17280CALL0 056.22TRUE00
2025-01-173016.5CALL0 141.91TRUE00
2025-01-173316.32CALL0 040.16TRUE00
2025-01-173515CALL0 1043.51TRUE00
2025-01-17388.4CALL1 134.85TRUE8.40
2025-01-17406.8CALL1 18832.17TRUE6.80
2025-01-17427.5CALL0 423.06TRUE00
2025-01-17454.25CALL0 1630.22TRUE00
2025-01-17472.75CALL1 14827.2FALSE2.750
2025-01-17501.9CALL0 31126.46FALSE00
2025-01-1752.51.45CALL0 101825.98FALSE00
2025-01-17550.65CALL3 127724.02FALSE-0.2-0.24
2025-01-1757.50.39CALL2 284223.53FALSE0.390
2025-01-17600.42CALL0 149924.08FALSE00
2025-01-1762.50.2CALL0 56550.85FALSE00
2025-01-17650.54CALL0 2520FALSE00
2025-01-17700.3CALL0 520FALSE00
2025-01-17750.1CALL0 700FALSE00
2025-01-17800.1CALL0 20FALSE00
2025-01-17850.1CALL0 150FALSE00
2025-01-17200.05PUT0 130FALSE00
2025-01-17250.1PUT0 250FALSE00
2025-01-17280.15PUT0 4328.52FALSE00
2025-01-17300.18PUT0 23228.47FALSE00
2025-01-17330.36PUT0 20827.35FALSE00
2025-01-17350.6PUT1 376023.94FALSE0.60
2025-01-17381.1PUT2 33022.33FALSE1.10
2025-01-17401.4PUT0 44320.54FALSE00
2025-01-17422.15PUT0 40617.74FALSE00
2025-01-17453.1PUT0 29917.76FALSE00
2025-01-17474.3PUT39 63814.19TRUE4.30
2025-01-17504.1PUT0 18813.6TRUE00
2025-01-1752.58.1PUT0 24232.83TRUE00
2025-01-17557.3PUT0 25616.6TRUE00
2025-01-1757.510.6PUT0 14841.7TRUE00
2025-01-176012.7PUT0 8421.1TRUE00
2025-01-1762.515.1PUT0 1229.45TRUE00
2025-01-176517.9PUT0 029.82TRUE00
2025-01-177024.6PUT0 136.28TRUE00
2025-01-177522.6PUT0 041.15TRUE00
2025-01-17800PUT0 049.13TRUE00
2025-01-17850PUT0 053.58TRUE00

Latest SNY Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST90$49.945
Jun 13, 2022 7:59 PM EST32$49.945
Jun 13, 2022 7:59 PM EST100$49.92
Jun 13, 2022 7:59 PM EST1$49.94
Jun 13, 2022 7:59 PM EST5$49.93

Sanofi (SNY) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-2611-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1121404/000110465920077215/0001104659-20-077215-index.htm
2019-12-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1121404/000000000019016674/0000000000-19-016674-index.htm
2020-01-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1121404/000000000020000685/0000000000-20-000685-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000021545719007294/0000215457-19-007294-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000083423720008778/0000834237-20-008778-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000089924319003822/0000899243-19-003822-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000089924319019809/0000899243-19-019809-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000089924319020073/0000899243-19-020073-index.htm
2020-07-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000089924320020277/0000899243-20-020277-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000089924320020587/0000899243-20-020587-index.htm
2019-06-2811-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1121404/000110465919038226/0001104659-19-038226-index.htm
2019-06-2811-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1121404/000110465919038230/0001104659-19-038230-index.htm
2020-05-26FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1121404/000110465920065593/0001104659-20-065593-index.htm
2020-06-2611-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1121404/000110465920077209/0001104659-20-077209-index.htm
2020-06-2611-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1121404/000110465920077215/0001104659-20-077215-index.htm
2020-03-0520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1121404/000112140420000006/0001121404-20-000006-index.htm
2020-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000112140420000015/0001121404-20-000015-index.htm
2020-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000112140420000017/0001121404-20-000017-index.htm
2020-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000112140420000020/0001121404-20-000020-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000114036119004808/0001140361-19-004808-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000114036119016600/0001140361-19-016600-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000114036119019468/0001140361-19-019468-index.htm
2019-12-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1121404/000114036119022193/0001140361-19-022193-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000114036120005506/0001140361-20-005506-index.htm
2020-03-1615-12BSecurities registration termination [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1121404/000114036120005872/0001140361-20-005872-index.htm
2020-03-1815-12B/ASecurities registration termination [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1121404/000114036120006142/0001140361-20-006142-index.htm
2020-05-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1121404/000114036120012717/0001140361-20-012717-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000114036120012718/0001140361-20-012718-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000114036120013625/0001140361-20-013625-index.htm
2020-06-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1121404/000114036120014084/0001140361-20-014084-index.htm
2019-02-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519026537/0001193125-19-026537-index.htm
2019-02-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519030709/0001193125-19-030709-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519033119/0001193125-19-033119-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519033125/0001193125-19-033125-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519033129/0001193125-19-033129-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519035454/0001193125-19-035454-index.htm
2019-02-15SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519041574/0001193125-19-041574-index.htm
2019-02-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519050684/0001193125-19-050684-index.htm
2019-03-0820-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1121404/000119312519068926/0001193125-19-068926-index.htm
2019-03-08IRANNOTICENotice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Acthttps://www.sec.gov/Archives/edgar/data/1121404/000119312519068940/0001193125-19-068940-index.htm
2019-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519079140/0001193125-19-079140-index.htm
2019-04-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519124231/0001193125-19-124231-index.htm
2019-05-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519136912/0001193125-19-136912-index.htm
2019-05-22SDhttps://www.sec.gov/Archives/edgar/data/1121404/000119312519153080/0001193125-19-153080-index.htm
2019-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519165623/0001193125-19-165623-index.htm
2019-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519167602/0001193125-19-167602-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519175326/0001193125-19-175326-index.htm
2019-07-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519194484/0001193125-19-194484-index.htm
2019-07-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519203054/0001193125-19-203054-index.htm
2019-07-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519204925/0001193125-19-204925-index.htm
2019-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519204959/0001193125-19-204959-index.htm
2019-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519205456/0001193125-19-205456-index.htm
2019-08-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519217509/0001193125-19-217509-index.htm
2019-09-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519235767/0001193125-19-235767-index.htm
2019-10-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519267571/0001193125-19-267571-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519280117/0001193125-19-280117-index.htm
2019-12-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519309382/0001193125-19-309382-index.htm
2019-12-09SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312519309390/0001193125-19-309390-index.htm
2019-12-10SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312519309771/0001193125-19-309771-index.htm
2019-12-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519309976/0001193125-19-309976-index.htm
2019-12-11SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312519310897/0001193125-19-310897-index.htm
2019-12-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519310949/0001193125-19-310949-index.htm
2019-12-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1121404/000119312519324104/0001193125-19-324104-index.htm
2019-12-27SC TO-TTender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312519324985/0001193125-19-324985-index.htm
2020-01-07SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520002606/0001193125-20-002606-index.htm
2020-01-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1121404/000119312520002611/0001193125-20-002611-index.htm
2020-01-09SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520004801/0001193125-20-004801-index.htm
2020-01-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1121404/000119312520006792/0001193125-20-006792-index.htm
2020-01-21SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520010588/0001193125-20-010588-index.htm
2020-01-23SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520012458/0001193125-20-012458-index.htm
2020-01-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520013048/0001193125-20-013048-index.htm
2020-02-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520022413/0001193125-20-022413-index.htm
2020-02-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520026621/0001193125-20-026621-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312520029094/0001193125-20-029094-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312520029096/0001193125-20-029096-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520047287/0001193125-20-047287-index.htm
2020-03-05IRANNOTICENotice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Acthttps://www.sec.gov/Archives/edgar/data/1121404/000119312520063078/0001193125-20-063078-index.htm
2020-03-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520064704/0001193125-20-064704-index.htm
2020-03-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520090307/0001193125-20-090307-index.htm
2020-04-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520095260/0001193125-20-095260-index.htm
2020-04-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520100308/0001193125-20-100308-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520107771/0001193125-20-107771-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520111679/0001193125-20-111679-index.htm
2020-04-23SDhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520116451/0001193125-20-116451-index.htm
2020-04-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520121046/0001193125-20-121046-index.htm
2020-04-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520126294/0001193125-20-126294-index.htm
2020-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520135917/0001193125-20-135917-index.htm
2020-05-13S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1121404/000119312520140966/0001193125-20-140966-index.htm
2020-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520142604/0001193125-20-142604-index.htm
2020-05-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520149265/0001193125-20-149265-index.htm
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520151283/0001193125-20-151283-index.htm
2020-05-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1121404/000119312520151324/0001193125-20-151324-index.htm
2020-05-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520152664/0001193125-20-152664-index.htm
2020-06-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520159251/0001193125-20-159251-index.htm
2020-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520162072/0001193125-20-162072-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520167522/0001193125-20-167522-index.htm
2020-06-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520171173/0001193125-20-171173-index.htm
2020-06-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520177538/0001193125-20-177538-index.htm
2020-07-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520188598/0001193125-20-188598-index.htm
2020-08-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520210507/0001193125-20-210507-index.htm
2020-08-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520212796/0001193125-20-212796-index.htm
2020-08-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520222513/0001193125-20-222513-index.htm
2020-08-18SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520222574/0001193125-20-222574-index.htm
2020-08-28SC TO-TTender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520233611/0001193125-20-233611-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520240726/0001193125-20-240726-index.htm
2020-09-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520245105/0001193125-20-245105-index.htm
2020-09-14SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520245221/0001193125-20-245221-index.htm
2020-09-22SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520250596/0001193125-20-250596-index.htm
2020-09-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520251082/0001193125-20-251082-index.htm
2020-09-28SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520255128/0001193125-20-255128-index.htm
2020-09-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520255624/0001193125-20-255624-index.htm
2020-10-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520261115/0001193125-20-261115-index.htm
2020-10-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520264582/0001193125-20-264582-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520271214/0001193125-20-271214-index.htm
2020-10-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520278007/0001193125-20-278007-index.htm
2020-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520282738/0001193125-20-282738-index.htm
2020-11-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520285498/0001193125-20-285498-index.htm
2020-08-04F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/1121404/000119380520000928/0001193805-20-000928-index.htm
2020-03-0425-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/1121404/000135445720000106/0001354457-20-000106-index.htm

Sanofi (SNY) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sanofi (SNY). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: < 1%
Institutional Ownership: 704%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-02-13 Sanofi10% Share HolderSell4,168,899.0037.66157,000,736.340.00https://www.sec.gov/Archives/edgar/data/1121404/000089924319003822/0000899243-19-003822-index.htm
2020-05-29 Sanofi10% Share HolderSell20,421,899.00509.8510,412,105,205.150.00https://www.sec.gov/Archives/edgar/data/1121404/000114036120012718/0001140361-20-012718-index.htm
2020-03-09 Sanofi10% Share HolderSell128,914.00489.6563,123,152.6220,421,899.00https://www.sec.gov/Archives/edgar/data/1121404/000114036120005506/0001140361-20-005506-index.htm
2019-09-10 Sanofi10% Share HolderSell172,904.00281.1548,611,803.9920,550,813.00https://www.sec.gov/Archives/edgar/data/1121404/000114036119016600/0001140361-19-016600-index.htm
2019-03-08 Sanofi10% Share HolderSell131,115.00412.1754,041,315.5420,723,717.00https://www.sec.gov/Archives/edgar/data/1121404/000114036119004808/0001140361-19-004808-index.htm
2020-06-09 Sanofi10% Share HolderSell120,234.00597.4871,837,410.32279,766.00https://www.sec.gov/Archives/edgar/data/1121404/000114036120013625/0001140361-20-013625-index.htm
2020-05-29 Sanofi10% Share HolderSell2,399,552.00509.851,223,411,587.20400,000.00https://www.sec.gov/Archives/edgar/data/1121404/000114036120012718/0001140361-20-012718-index.htm
2020-07-28 Sanofi10% Share HolderBuy81,250.0016.001,300,000.00520,125.00https://www.sec.gov/Archives/edgar/data/1121404/000089924320020587/0000899243-20-020587-index.htm
2019-07-22 Sanofi10% Share HolderBuy93,750.0016.001,500,000.00558,035.00https://www.sec.gov/Archives/edgar/data/1121404/000089924319020073/0000899243-19-020073-index.htm